chr16-20559353-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105069.2(ACSM2B):āc.272A>Gā(p.Gln91Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000876 in 1,609,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001105069.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACSM2B | NM_001105069.2 | c.272A>G | p.Gln91Arg | missense_variant | 3/14 | ENST00000329697.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACSM2B | ENST00000329697.10 | c.272A>G | p.Gln91Arg | missense_variant | 3/14 | 1 | NM_001105069.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151940Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000290 AC: 7AN: 241744Hom.: 0 AF XY: 0.0000305 AC XY: 4AN XY: 131012
GnomAD4 exome AF: 0.0000947 AC: 138AN: 1457702Hom.: 0 Cov.: 35 AF XY: 0.0000842 AC XY: 61AN XY: 724670
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152058Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.272A>G (p.Q91R) alteration is located in exon 4 (coding exon 2) of the ACSM2B gene. This alteration results from a A to G substitution at nucleotide position 272, causing the glutamine (Q) at amino acid position 91 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at